Use of the LLC Holding Company Structure by Life Sciences Companies
- 8.4.2025
- A. William Caporizzo, Meghan Walsh, Stuart Falber
Life sciences companies (particularly early stage companies) may be attracted to an LLC holding company structure as an alternative to a typical C corporation structure to maximize both the purchase price paid by a future acquiror of a drug development program and the after-tax proceeds realized by the company’s investors upon a sale. A description of the LLC holding company structure and its pros and cons is found here. For further questions, reach out to either Bill Caporizzo or Meghan Walsh in WilmerHale’s Tax Practice or Stuart Falber in WilmerHale’s Life Sciences Group.
